CompletedNot Applicable

Prognostic Value of Finger Blood Pressure in Arteriovenous Fistula Care

Singapore20 participantsStarted 2019-08-05

Plain-language summary

The goal of this trial is to investigate the prognostic value of monitoring finger blood pressures (FBPs) in predicting the success of surgically created arteriovenous fistula (AVF) for patients with end stage renal disease. The main questions it aims to answer is: \- Can FBPs predict AVF maturation? Participants will undergo FBP measurements at pre-op, immediately post-op, 4 weeks and 6 weeks post-AVF creation.

Who can participate

Age range21 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants has documented Chronic Kidney Disease (CKD), determined by Glomerular Filtration Rate (GFR) * Participant is recommended for renal replacement therapy based on clinical assessment of renal function as well as CKD staging, as documented in clinical notes. * Haemodialysis was chosen as the most appropriate renal replacement therapy * Participant is able to consent to the creation of an AVF in preparation for hemodialysis. * Participant is able to adhere to follow-up assessments of AVF maturation, if applicable. Exclusion Criteria: * Subject had a previous AVF and is now undergoing surgery for another AVF creation * Subject has amputation distal to AVF * Subject is pregnant or planning to conceive * Participants is unable to consent

What they're measuring

Correlation between AVF maturation and changes in Finger Blood Pressure measurements at baseline and immediately post-op

Timeframe: Within 24 hours

Trial details

NCT IDNCT06765577

SponsorSingapore General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-27

View on ClinicalTrials.gov More End Stage Renal Disease trials